City

Nanjing (1)

Condition

Intravenous Infusion Reaction (1)

Obinutuzumab (1)

Rapid Infusion (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

The First Affiliated Hospital with Nanjing Medical University (1)

Collaborator

Intervention

intravenous rapid infusion of obinutuzumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

rapid infusion

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Obinutuzumab, Rapid Infusion, Intravenous Infusion Reaction Trial in Nanjing (intravenous rapid infusion of obinutuzumab)

Recruiting

Obinutuzumab
+2 more

intravenous rapid infusion of obinutuzumab

Nanjing, Jiangsu, China

Jiangsu Province Hospital

Aug 18, 2022